Pharma-Bio Serv, Inc.
PBSV · OTC
10/31/2024 | 10/31/2023 | 10/31/2022 | 10/31/2021 | |
|---|---|---|---|---|
| Revenue | $9,509 | $16,977 | $19,399 | $20,115 |
| % Growth | -44% | -12.5% | -3.6% | – |
| Cost of Goods Sold | $6,993 | $11,910 | $14,517 | $14,755 |
| Gross Profit | $2,516 | $5,066 | $4,881 | $5,360 |
| % Margin | 26.5% | 29.8% | 25.2% | 26.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $3,804 | $3,949 | $3,707 | $9,214 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $13 | $0 |
| Operating Expenses | $3,804 | $3,949 | $3,707 | $9,214 |
| Operating Income | -$1,288 | $1,117 | $1,175 | -$3,854 |
| % Margin | -13.5% | 6.6% | 6.1% | -19.2% |
| Other Income/Exp. Net | $532 | $570 | $13 | $1,978 |
| Pre-Tax Income | -$755 | $1,687 | $1,188 | -$1,876 |
| Tax Expense | $22 | $377 | $182 | $213 |
| Net Income | -$778 | $1,310 | $1,007 | -$2,089 |
| % Margin | -8.2% | 7.7% | 5.2% | -10.4% |
| EPS | -0.034 | 0.057 | 0.044 | -0.091 |
| % Growth | -159.5% | 30.1% | 148.3% | – |
| EPS Diluted | -0.034 | 0.057 | 0.044 | -0.091 |
| Weighted Avg Shares Out | 22,966 | 22,971 | 23,003 | 23,026 |
| Weighted Avg Shares Out Dil | 22,966 | 22,998 | 23,032 | 23,026 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $181 | $194 | $51 | $73 |
| EBITDA | -$1,106 | $1,312 | $1,226 | -$3,781 |
| % Margin | -11.6% | 7.7% | 6.3% | -18.8% |